The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.
Top 5 Upgrades:
-
Guggenheim upgraded Quanta Services(PWR) to Buy from Neutral with an $800 price target. A “strong” Q2 report “validates the underlying value premise rather than simply reflecting a favorable outcome for the quarter,” says the firm, which has raised estimates “substantially” for 2027-2030.
-
Stifel upgraded Saia(SAIA) to Buy from Hold with a price target of $438, down from $450. There was “noise” in reported KPIs that led to some confusion amongst investors and the Street, but the firm believes they “should be focused” on revenue per shipment, contract renewals, above-seasonal operating ratio trends and record service levels, as these are “the enabler of core pricing.”
-
Piper Sandler upgraded Replimune(REPL) to Overweight from Neutral with a price target of $14, up from $9. The postive FDA panel vote supporting RP1 approval for advanced melanoma after anti-PD-1 failure “makes approval the most likely outcome of the BLA’s third review,” the firm tells investors. Cantor Fitzgerald also upgraded Replimune to Overweight from Neutral without a price target citing the FDA panel vote supporting RP1 approval for advanced melanoma after anti-PD-1 failure.
-
BMO Capital upgraded Nextpower(NXT) to Outperform from Market Perform with an unchanged price target of $132, offering 36% upside. The recent selloff has created an “attractive opportunity to own what we view as one of the highest-quality utility-scale solar platforms,” the firm tells investors in a research note.
-
Deutsche Bank upgraded International Paper(IP) to Buy from Hold with a price target of $50, up from $39. The firm sees a favorable risk/reward following the company’s Q2 report.
-
Benchmark downgraded Roblox(RBLX) to Sell from Hold with a $33 price target. Noting that Q3 guidance was substantially below expectations and that management also withdrew annual guidance, the firm believes the platform may be entering lifecycle decline as weakness broadens from new-user acquisition in Q1 to monetization in Q2. BTIG also cut its rating on Roblox to Sell following quarterly results, while Deutsche Bank and BMO Capital downgraded the stock to Neutral-equivalent ratings.
-
Argus downgraded Boston Scientific(BSX) to Hold from Buy. The firm notes that the company faces headwinds to growth and key product platforms, including Watchman and electrophysiology, which had been high-growth areas in 2025 but faced declines in the second half of 2026.
-
UBS downgraded MarketAxess(MKTX) to Neutral from Buy with a price target of $167, down from $200, after the company entered into an agreement to be acquired by IntercontinentalExchange (ICE) for $167 per common share.
-
Raymond James downgraded GoDaddy(GDDY) to Outperform from Strong Buy with a $100 price target. AIRO’s rapid annual recurring revenue ramp is encouraging, but lower long-term estimates and valuation considerations lead to a downgrade to Outperform pending clearer visibility into durable growth trends, the firm tells investors in a research note.
-
Raymond James downgraded Coastal Financial(CCB) to Outperform from Strong Buy with a price target of $50, down from $100. Coastal reported a significantly weaker Q2 due to $68.8M in charges tied to a single CCBX partner, prompting a higher risk premium on the BaaS model until management proves the issue was isolated, the firm tells investors in a research note.
